Peter R. Strack

3.6k total citations · 2 hit papers
34 papers, 2.8k citations indexed

About

Peter R. Strack is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Peter R. Strack has authored 34 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 12 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Peter R. Strack's work include Developmental Biology and Gene Regulation (7 papers), Cancer-related Molecular Pathways (6 papers) and Advanced Breast Cancer Therapies (4 papers). Peter R. Strack is often cited by papers focused on Developmental Biology and Gene Regulation (7 papers), Cancer-related Molecular Pathways (6 papers) and Advanced Breast Cancer Therapies (4 papers). Peter R. Strack collaborates with scholars based in United States, United Kingdom and Japan. Peter R. Strack's co-authors include Peggy Beer‐Romero, Chia‐Yu Chu, Jeffrey Winston, J. Wade Harper, Stephen J. Elledge, Jennifer O’Neil, A. Thomas Look, Giulio Draetta, Christopher Winter and Lucio Miele and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Genes & Development.

In The Last Decade

Peter R. Strack

34 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The SCFbeta -TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in Ikappa Balpha and beta -catenin and stimulates Ikappa Balpha ubiquitination in vitro

1999 801 citations Jeffrey Winston, Peter R. Strack et al. Genes & Development profile →
FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors

2007 523 citations Jennifer O’Neil, Peter R. Strack et al. profile →

Peers

Countries citing papers authored by Peter R. Strack

Since Specialization

Citations

This map shows the geographic impact of Peter R. Strack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter R. Strack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter R. Strack more than expected).

Fields of papers citing papers by Peter R. Strack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter R. Strack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter R. Strack. The network helps show where Peter R. Strack may publish in the future.

Co-authorship network of co-authors of Peter R. Strack

This figure shows the co-authorship network connecting the top 25 collaborators of Peter R. Strack. A scholar is included among the top collaborators of Peter R. Strack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter R. Strack. Peter R. Strack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Combined Inhibition of Cyclin-Dependent Kinases (Dinaciclib) and AKT (MK-2206) Blocks Pancreatic Tumor Growth and Metastases in Patient-Derived Xenograft Models 2015 ·Molecular Cancer Therapeutics ·Chaoxin Hu, (unknown), Venugopal Chenna, Shinichi Yabuuchi, Rajat Bannerji, Robert Booher, Peter R. Strack, Nilofer S. Azad, Barry D. Nelkin, Anirban Maitra	60
2	Pharmacological Inhibition of O-GlcNAcase Does Not Increase Sensitivity of Glucocorticoid Receptor-Mediated Transrepression 2015 ·PLoS ONE ·(unknown), (unknown), Alexandra Hicks, Huseyin Mehmet, Melody K. Morris, (unknown), Peter R. Strack, Mary J. Savage, Dennis M. Zaller, (unknown), Philip E. Brandish	5
3	Crosstalk between PKCα and Notch-4 in endocrine-resistant breast cancer cells 2013 ·Oncogenesis ·Jieun Yun, Antonio Pannuti, Ignacio Espinoza, He Zhu, Chindo Hicks, Xulong Zhu, (unknown), Paola Rizzo, Gwendolyn D'Souza, (unknown), Mitchell F. Denning, John S. Coon, Mu Sun, Emery H. Bresnick, Clodia Osipo, Jing Wu, Peter R. Strack, Debra A. Tonetti, Lucio Miele	56
4	A zinc finger nuclease assay to rapidly quantitate homologous recombination proficiency in human cell lines 2012 ·Analytical Biochemistry ·Jing Yuan, Peter R. Strack, Carlo Toniatti, Marc R. Pelletier	3
5	Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation. 2010 ·PubMed ·(unknown), Shelly S. Lo, Kathy S. Albain, Patricia A. Robinson, Prabha Rajan, Peter R. Strack, Todd E. Golde, Lucio Miele, Kimberly E. Foreman	119
6	Downregulation of Notch Pathway by a γ-Secretase Inhibitor Attenuates AKT/Mammalian Target of Rapamycin Signaling and Glucose Uptake in an ERBB2 Transgenic Breast Cancer Model 2010 ·Cancer Research ·Clay L. Efferson, Christopher T. Winkelmann, Christopher Ware, Timothy M. Sullivan, Saverio Giampaoli, Jennifer Tammam, Shailendra B. Patel, Giuseppe Mesiti, John F. Reilly, Raymond E. Gibson, Carolyn A. Buser, Timothy J. Yeatman, Domenico Coppola, Christopher Winter, Edwin Clark, Giulio Draetta, Peter R. Strack, Pradip K. Majumder	76
7	Inhibition of Notch Signaling Blocks Growth of Glioblastoma Cell Lines and Tumor Neurospheres 2010 ·Genes & Cancer ·Y-H. Chen, Santosh Kesari, Cliona M. Rooney, Peter R. Strack, Huangxuan Shen, Lizi Wu, J D Griffin	83
8	Inhibition of NOTCH Signaling by Gamma Secretase Inhibitor Engages the RB Pathway and Elicits Cell Cycle Exit in T-Cell Acute Lymphoblastic Leukemia Cells 2009 ·Cancer Research ·Sudhir Rao, Jennifer O’Neil, (unknown), James S. Hardwick, Xudong Dai, Theresa Zhang, Edyta Tyminski, Jing Yuan, Nancy E. Kohl, Victoria M. Richon, Lex H.T. Van der Ploeg, Pamela M. Carroll, Giulio Draetta, A. Thomas Look, Peter R. Strack, Christopher Winter	114
9	Opposite Effects of Notch-1 and Notch-2 on Mesothelioma Cell Survival under Hypoxia Are Exerted through the Akt Pathway 2008 ·Cancer Research ·Irene Graziani, (unknown), Melissa A. De Marco, Yuanbin Chen, Harvey I. Pass, (unknown), Peter R. Strack, Lucio Miele, Maurizio Bocchetta	94
10	Oxygen Concentration Determines the Biological Effects of NOTCH-1 Signaling in Adenocarcinoma of the Lung 2007 ·Cancer Research ·Yuanbin Chen, Melissa A. De Marco, Irene Graziani, Adi F. Gazdar, Peter R. Strack, Lucio Miele, Maurizio Bocchetta	123
11	Kinetic analysis of the fatty acid synthesis pathway in HCT-116 colon cancer cells: role of FAS and ACC1 in maintaining tumor cell viability and proliferation 2007 ·Cancer Research ·Nicole Ginanni, Yanai Zhan, Michael R. Tota, Margaret Wu, Jennifer A. Roth, Dennis A. Ridenour, Peter R. Strack, Nathan Bays, Eric Bachman, Victoria M. Richon, Nancy E. Kohl, Stefan Krauß	2
12	Apoptosis in T Cell Acute Lymphoblastic Leukemia Cells after Cell Cycle Arrest Induced by Pharmacological Inhibition of Notch Signaling 2007 ·Chemistry & Biology ·Huw D. Lewis, (unknown), Peter R. Strack, (unknown), Jennifer O’Neil, (unknown), Andrew Madin, (unknown), A. Thomas Look, Nancy E. Kohl, Giulio Draetta, Timothy Harrison, Julie Kerby, Mark S. Shearman, Dirk Beher	110
13	3-Aryl-4-hydroxyquinolin-2(1H)-one derivatives as type I fatty acid synthase inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·Alexey Rivkin, (unknown), Mark T. Goulet, Nathan Bays, (unknown), Ilona Kariv, Stefan Krauß, Nicole Ginanni, Peter R. Strack, Nancy E. Kohl, Caroline Chung, Jeffrey P. Varnerin, Paul N. Goudreau, Amy Chang, Michael R. Tota, Benito Muñoz	42
14	SCFβ-TRCP and phosphorylation dependent ubiquitination of IκBα catalyzed by Ubc3 and Ubc4 2000 ·Oncogene ·Peter R. Strack, Maureen Caligiuri, Marc R. Pelletier, M Boisclair, Anne M. Theodoras, Peggy Beer‐Romero, Susan Glass, Tom Parsons, Robert A. Copeland, K R Auger, Pamela A. Benfield, Leonardo Brizuela, Mark Rolfe	33
15	The SCFbeta -TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in Ikappa Balpha and beta -catenin and stimulates Ikappa Balpha ubiquitination in vitro breakdown → 1999 ·Genes & Development ·Jeffrey Winston, Peter R. Strack, Peggy Beer‐Romero, Chia‐Yu Chu, Stephen J. Elledge, J. Wade Harper	801
16	A Cellular Anti-Apoptosis Protein is Cleaved by the HIV-1 Protease 1998 ·Advances in experimental medicine and biology ·Bruce D. Korant, Peter R. Strack, Michelle West Frey, (unknown)	18
17	HIV Protease Mutations Leading to Reduced Inhibitor Susceptibility 1996 ·Advances in experimental medicine and biology ·Bruce D. Korant, Zhijian Lu, Peter R. Strack, (unknown)	2
18	ATP-Stimulated Degradation of Oxidatively Modified Superoxide Dismutase by Cathepsin D in Cardiac Tissue Extracts 1996 ·Biochemical and Biophysical Research Communications ·Peter R. Strack, Lloyd Waxman, Julie M. Fagan	8
19	Comparison of the multicatalytic proteinases isolated from the nucleus and cytoplasm of chicken red blood cells 1992 ·International Journal of Biochemistry ·Peter R. Strack, (unknown), Lloyd Waxman, Julie M. Fagan	11
20	Purification of the multicatalytic proteinase from the nucleus and cytoplasm of chicken red blood cells. 1991 ·PubMed ·Peter R. Strack, (unknown), Lloyd Waxman, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact